Try our Advanced Search for more refined results
July 07, 2015
Bristol-Myers Squibb Co. et al v. Merck & Co., Inc. et al
Case Number:
1:15-cv-00572
Court:
Nature of Suit:
Judge:
Firms
Companies
- Bristol-Myers Squibb Co.
- Dana-Farber Cancer Institute Inc.
- Merck & Co. Inc.
- Ono Pharmaceutical Co. Ltd
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
January 20, 2017
Merck Pays Bristol-Myers $625M In Cancer Treatment IP Row
Merck will pay Bristol-Myers Squibb $625 million to end an ongoing intellectual property battle over an immunotherapy cancer treatment, the companies announced on Friday, ending multiple cases including three lawsuits in Delaware federal court and setting up a 10-year licensing agreement.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login